It remains to be clarified whether the gut microbiota-eCBome axis is involved in the control of intestinal LEAP2 levels, especially during obesity and hyperglycemia, where, as shown previously and confirmed here, all the members of this triangle undergo adaptive regulation. Here, LEAP2 is linked to obesity due to melanocortin 4 receptor deficiency.